Supply Chain

Minneapolis-based Medtronic is preparing to sell part or all of its medical supplies business, an unnamed source told Bloomberg.

U.S. Rep. Peter Welch, D-Vt., on Monday unveiled his plan to make prescription drugs more affordable for consumers, taxpayers and businesses providing health coverage to employees during an affordable medicine roundtable. 

Consumer confidence dropped in January after hitting a 15-year high in December, reports The Wall Street Journal.

Amazon will build an air cargo hub to accommodate its growing fleet of planes —another move in the Seattle-based retailer's transformation into a logistics provider, reports The Wall Street Journal.

Planning for supply chain interruptions should take place well before a disaster actually occurs, reports Manufacturing.net.

Minneapolis-based Medtronic earned clearance from the Food and Drug Administration for its CardioInsight Noninvasive 3-D Mapping System.

Japanese drugmaker Takeda Pharmaceuticals Co. on Wednesday said it would maintain its pricing model in the U.S., despite President Trump's demands to lower drug costs in the country, reports Reuters.

Do you know how long it takes to make a purchase decision in your facility – from the time a need arises to the time a decision is made? Research indicates that most purchase cycles in hospitals are about one…

While President Donald Trump is calling on drug companies to bring production back to the U.S., the shift may prove difficult for the pharmaceutical industry, reports The Wall Street Journal.

STAT spoke with pharmaceutical insiders, physicians, Wall Street analysts and FDA veterans about the potential benefits and consequences of President Donald Trump's plan to deregulate the FDA and speed up the approval process for drugs and devices.